We are evaluating the safety of an oral medication called INF904 for people with moderate to severe chronic spontaneous urticaria or hidradenitis suppurativa. This study will help us understand how the medication works in the body.
Health conditions and diseases that the clinical trial is designed to study and treat.
Chronic Spontaneous Urticaria (CSU) is a condition characterized by the presence of hives or welts on the skin that occur spontaneously and can last for six weeks or longer. It can cause significant itching and discomfort.
Hidradenitis Suppurativa (HS) is a chronic skin condition that causes painful lumps under the skin, often in areas where skin rubs together, such as the armpits and groin. It can lead to abscesses and scarring.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
